{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:27:01Z","timestamp":1790965621057,"version":"4.1.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To develop a CT-based radiomics model and a combined model for preoperatively discriminating infiltrative renal cell carcinoma (RCC) and pyelocaliceal upper urinary tract urothelial carcinoma (UTUC), which invades the renal parenchyma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Eighty patients (37 pathologically proven infiltrative RCCs and 43 pathologically proven pyelocaliceal UTUCs) were retrospectively enrolled and randomly divided into a training set (n = 56) and a testing set (n = 24) at a ratio of 7:3. Traditional CT imaging characteristics in the portal venous phase were collected by two radiologists (SPH and ZXL, who have 4 and 30 years of experience in abdominal radiology, respectively). Patient demographics and traditional CT imaging characteristics were used to construct the clinical model. The radiomics score was calculated based on the radiomics features extracted from the portal venous CT images and the random forest (RF) algorithm to construct the radiomics model. The combined model was constructed using the radiomics score and significant clinical factors according to the multivariate logistic regression. The diagnostic efficacy of the models was evaluated using receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The RF score based on the eight validated features extracted from the portal venous CT images was used to build the radiomics model. Painless hematuria as an independent risk factor was used to build the clinical model. The combined model was constructed using the RF score and the selected clinical factor. Both the radiomics model and combined model showed higher efficacy in differentiating infiltrative RCC and pyelocaliceal UTUC in the training and testing cohorts with AUC values of 0.95 and 0.90, respectively, for the radiomics model and 0.99 and 0.90, respectively, for the combined model. The decision curves of the combined model as well as the radiomics model indicated an overall net benefit over the clinical model. Both the radiomics model and the combined model achieved a notable reduction in false-positive and false-negativerates, resulting in significantly higher accuracy compared to the visual assessments in both the training and testing cohorts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The radiomics model and combined model had the potential to accurately differentiate infiltrative RCC and pyelocaliceal UTUC, which invades the renal parenchyma, and provide a new potentially non-invasive method to guide surgery strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1244585","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T04:46:43Z","timestamp":1705553203000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["CT\u2212based radiomics signature for differentiating pyelocaliceal upper urinary tract urothelial carcinoma from infiltrative renal cell carcinoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaoli","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangkun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009667","article-title":"Population attributable risk of renal cell cancer in Minnesota","volume":"148","author":"Benichou","year":"1998","journal-title":"Am J Epidemiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupr\u00eat","year":"2023","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.urology.2020.06.038","article-title":"Infiltrative renal masses: clinical challenges","volume":"145","author":"Palacios","year":"2020","journal-title":"Urology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8867","article-title":"Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review","volume":"16","author":"Ding","year":"2018","journal-title":"Oncol Lett"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1148\/radiographics.20.1.g00ja08215","article-title":"From the archives of the AFIP. Infiltrative renal lesions: radiologic-pathologic correlation. Armed Forces Institute of Pathology","volume":"20","author":"Pickhardt","year":"2000","journal-title":"Radiographics: Rev Publ Radiological Soc North America Inc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","article-title":"European association of urology guidelines on renal cell carcinoma: the 2022 update","volume":"82","author":"Ljungberg","year":"2022","journal-title":"Eur Urol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1148\/rg.2021200123","article-title":"Infiltrative renal Malignancies: imaging features, prognostic implications, and mimics","volume":"41","author":"Sweet","year":"2021","journal-title":"Radiographics: Rev Publ Radiological Soc North America Inc"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2015.07.006","article-title":"Contrast-enhanced CT in 100 clear cell renal cell cancers - an analysis of enhancement, tumour size, and survival","volume":"70","author":"Veeratterapillay","year":"2015","journal-title":"Clin Radiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2017.18.3.452","article-title":"Gastrointestinal involvement of recurrent renal cell carcinoma: CT findings and clinicopathologic features","volume":"18","author":"Park","year":"2017","journal-title":"Korean J Radiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.149190","article-title":"Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio","volume":"128","author":"Ren","year":"2015","journal-title":"Chin Med J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.12659\/PJR.901957","article-title":"Role of contrast enhancement and corrected attenuation values of renal tumors in predicting renal cell carcinoma (RCC) subtypes: protocol for a triphasic multi-slice computed tomography (CT) procedure","volume":"82","author":"Ertekin","year":"2017","journal-title":"Polish J Radiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40644-022-00444-8","article-title":"Is a single portal venous phase in contrast-enhanced CT sufficient to detect metastases or recurrence in clear cell renal cell carcinoma? - a single-center retrospective study","volume":"22","author":"Hagen","year":"2022","journal-title":"Cancer imaging: Off Publ Int Cancer Imaging Soc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7376","article-title":"Centrally infiltrating renal masses on CT: differentiating intrarenal transitional cell carcinoma from centrally located renal cell carcinoma","volume":"198","author":"Raza","year":"2012","journal-title":"AJR. Am J roentgenology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-005-0078-0","article-title":"Multiphasic multidetector-row CT (MDCT) in detection and staging of transitional cell carcinomas of the upper urinary tract","volume":"16","author":"Fritz","year":"2006","journal-title":"Eur Radiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7747","article-title":"Renal cell carcinoma: value of multiphase MDCT with multiplanar reformations in the detection of pseudocapsule","volume":"199","author":"Tsili","year":"2012","journal-title":"AJR. Am J roentgenology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.11101508","article-title":"Clear cell renal cell carcinoma: multiphasic multidetector CT imaging features help predict genetic karyotypes","volume":"261","author":"Sauk","year":"2011","journal-title":"Radiology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.13.10673","article-title":"Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma","volume":"201","author":"Wehrli","year":"2013","journal-title":"AJR. Am J roentgenology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_217_16","article-title":"Differentiating renal pelvic cancer from renal cell carcinoma with 18-fluorodeoxyglucose positron emission tomography-computed tomography","volume":"17","author":"Dursun","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine. Nature reviews","volume":"14","author":"Lambin","year":"2017","journal-title":"Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i11","article-title":"Feature selection with the boruta package","volume":"36","author":"Kursa","year":"2010","journal-title":"J Stat Softw"},{"key":"B23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eswa.2019.05.028","article-title":"A comparison of random forest variable selection methods for classification prediction modeling","volume":"134","author":"Speiser","year":"2019","journal-title":"Expert Syst Appl"},{"key":"B24","volume-title":"Fast unified Random Forests for Survival, Regression, and Classification (RF-SRC)","author":"Ishwaran","year":"2014"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-012-0885-2","article-title":"Ureteral tumours showing a worse prognosis than renal pelvis tumours may be attributed to ureteral tumours more likely to have hydronephrosis and less likely to have haematuria","volume":"31","author":"Zhang","year":"2013","journal-title":"World J Urol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2021200202","article-title":"Role of imaging in renal cell carcinoma: A multidisciplinary perspective","volume":"41","author":"Elkassem","year":"2021","journal-title":"Radiographics: Rev Publ Radiological Soc North America Inc"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.25493","article-title":"Update on the role of imaging in clinical staging and restaging of renal cell carcinoma based on the AJCC 8th edition, from the AJR special series on cancer staging","volume":"217","author":"Elkassem","year":"2021","journal-title":"AJR. Am J roentgenology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.974485","article-title":"Radiomics analysis of contrast-enhanced CT scans can distinguish between clear cell and non-clear cell renal cell carcinoma in different imaging protocols","volume":"9","author":"Budai","year":"2022","journal-title":"Front Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1244585\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T04:46:45Z","timestamp":1705553205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1244585\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":28,"alternative-id":["10.3389\/fonc.2023.1244585"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1244585","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"article-number":"1244585"}}